Suppr超能文献

链脲佐菌素诱导的糖尿病对大鼠小冠状动脉平滑肌细胞中钾通道的影响。

Effects of streptozotocin-induced diabetes on Kv channels in rat small coronary smooth muscle cells.

作者信息

Chai Qiang, Liu Zhixiang, Chen Lianbi

机构信息

Institute of Physiology, School of Medicine, Shandong University, Jinan, Shandong Province, 250000, People's Republic of China.

出版信息

Chin J Physiol. 2005 Mar 31;48(1):57-63.

Abstract

Diabetes impairs endothelium dependent vasodilation, but the mechanism of endothelium independent dilation is not well understood. In the present study, we examined the effect of streptozotocin (STZ)-induced diabetes on the vasomotor of small coronary artery and the activity of voltage-dependent K+ channel of vascular smooth muscle cells in STZ rats [corrected] using the videomicroscopy and patch clamp method. STZ-induced diabetes appeared to [corrected] reduce the vasodilation induced by beta-adrenoceptor agonist, isoproterenol (10(-9)-10(-5) mol/l), and adenylyl cyclase activator forskolin (10(-9)-10(-5) mol/l) respectively (isoproterenol: 44.2 +/- 6.7% vs. 82.5 +/- 4.8%, and forskolin: 54.4 +/- 4.5% vs. 94.3 +/- 2.4%). 4-AP, a Kv channel blocker of VSMC, further decreased dilation to isoproterenol (44.2 +/- 6.7% vs. 10.2 +/- 3.5%) and forskolin (54.4 +/- 4.5% vs. 13.8 +/- 11.0%) significantly. Whole cell K+ current recording demonstrated that STZ-induced diabetes decreased isoproterenol and forskolin-induced K+ current (ISO: 55.6 +/- 7.8 pA/pF vs. 28.4 +/- 3.4 pA/pF, forskolin: 61.3 +/- 9.8 pA/pF vs. 32.4 +/- 3.4 pA/pF). 4-AP further reduced the decreased K+ current (ISO: 28.4 +/- 3.4 pA/pF vs. 14.3 +/- 2.1 pA/pF, forskolin: 32.4 +/- 3.4 pA/pF vs. 14.8 +/- 2.9 pA/pF). These results indicated that STZ-induced diabetes impaired cAMP mediated dilation of small coronary artery and suppressed the Kv channel activity of vascular smooth muscle cells. Kv channel of VSMC was shown to play a determinate role reducing dilation of small coronary artery in STZ rats.

摘要

糖尿病会损害内皮依赖性血管舒张功能,但内皮非依赖性舒张的机制尚不清楚。在本研究中,我们使用视频显微镜和膜片钳方法,研究了链脲佐菌素(STZ)诱导的糖尿病对STZ大鼠小冠状动脉血管舒缩功能以及血管平滑肌细胞电压依赖性钾通道活性的影响。STZ诱导的糖尿病似乎分别降低了β-肾上腺素能受体激动剂异丙肾上腺素(10⁻⁹ - 10⁻⁵ mol/L)和腺苷酸环化酶激活剂福斯高林(10⁻⁹ - 10⁻⁵ mol/L)诱导的血管舒张(异丙肾上腺素:44.2±6.7% 对 82.5±4.8%,福斯高林:54.4±4.5% 对 94.3±2.4%)。4-氨基吡啶(4-AP),一种血管平滑肌细胞的钾通道阻滞剂,进一步显著降低了对异丙肾上腺素(44.2±6.7% 对 10.2±3.5%)和福斯高林(54.4±4.5% 对 13.8±11.0%)的舒张反应。全细胞钾电流记录表明,STZ诱导的糖尿病降低了异丙肾上腺素和福斯高林诱导的钾电流(异丙肾上腺素:55.6±7.8 pA/pF 对 28.4±3.4 pA/pF,福斯高林:61.3±9.8 pA/pF 对 32.4±3.4 pA/pF)。4-AP进一步降低了降低的钾电流(异丙肾上腺素:28.4±3.4 pA/pF 对 14.3±2.1 pA/pF,福斯高林:32.4±3.4 pA/pF 对 14.8±2.9 pA/pF)。这些结果表明,STZ诱导的糖尿病损害了cAMP介导的小冠状动脉舒张功能,并抑制了血管平滑肌细胞的钾通道活性。血管平滑肌细胞的钾通道在降低STZ大鼠小冠状动脉舒张中起决定性作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验